Episurf Medical AB (publ) (STO:EPIS.B)
Sweden · Delayed Price · Currency is SEK 0.0745
-0.0021 (-2.74%)
Sep 4, 2026, 5:29 PM CET
Episurf Medical AB Revenue
In the year 2025, Episurf Medical AB had annual revenue of 22.80M SEK with 10.14% growth.
Revenue
22.80M
Revenue Growth
+13.43%
P/S Ratio
31.37
Revenue / Employee
1.24M
Employees
21
Market Cap
818.73M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.80M | 2.10M | 10.14% |
| Dec 31, 2024 | 20.70M | 600.00K | 2.99% |
| Dec 31, 2023 | 20.10M | 1.90M | 10.44% |
| Dec 31, 2022 | 18.20M | 4.40M | 31.88% |
| Dec 31, 2021 | 13.80M | 6.80M | 97.14% |
| Dec 31, 2020 | 7.00M | 1.60M | 29.63% |
| Dec 31, 2019 | 5.40M | 1.10M | 25.58% |
| Dec 31, 2018 | 4.30M | 1.20M | 38.71% |
| Dec 31, 2017 | 3.10M | 439.46K | 16.52% |
| Dec 31, 2016 | 2.66M | -3.98M | -59.96% |
| Dec 31, 2015 | 6.65M | 4.31M | 184.04% |
| Dec 31, 2014 | 2.34M | 643.54K | 37.95% |
| Dec 31, 2013 | 1.70M | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | 2.47M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BICO Group AB | 1.50B |
| C-Rad AB | 444.40M |
| Paxman AB | 365.91M |
| Mentice AB | 303.13M |
| Devyser Diagnostics AB | 250.30M |
| Bactiguard Holding AB | 206.94M |
| Sedana Medical AB | 195.46M |
| OssDsign AB | 163.80M |
Episurf Medical AB News
- 11 days ago - Episurf Medical AB Quarterly report: Q2 2026 - Filings
- 3 months ago - Episurf Medical AB Quarterly report: Q1 2026 - Filings
- 7 months ago - Episurf Medical AB Annual report: Q4 2025 - Filings
- 7 months ago - Episurf Medical AB Quarterly report: Q4 2025 - Filings
- 10 months ago - Episurf Medical AB Quarterly report: Q3 2025 - Filings